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BY-NC-ND license (http://creativecomAbstract Objective: 3,4-Oxo-isopropylidene-shikimic acid (ISA), a derivative of shikimic
acid, has exhibited ameliorative effect on cognitive impairment in experimental animal
models of dementia. This study investigated the effect of ISA on lipid accumulation and adipo-
kine secretion during differentiation of 3T3-L1 fibroblasts to adipocytes.
Methods: 3T3-L1 cells were cultured and treated with ISA (50e800 mM) from days 3e8. Lipid
accumulation and triglyceride content were measured. Gene expression of adipokines (adipo-
nectin, leptin, and resistin), CCAAT/enhancer binding protein (C/EBP) b, C/EBP a and perox-
isome proliferator-activated receptor g (PPAR g) and PPAR target genes, including adipocyte
fatty acid binding protein (aP2) and fatty acid synthase (FAS) were investigated.
Results: ISA promoted 3T3-L1 fibroblast differentiation to adipocytes and increased triglycer-
ide content by 26%. On mechanistic levels, ISA increased expressions of C/EBP b, PPAR g, C/
EBP a, aP2 and FAS. Moreover, ISA stimulated expressions of adipokines secreted by adipo-
cytes, including adiponectin, leptin, and resistin.
Conclusions: These findings demonstrated that ISA promoted adipogenesis by up-regulating ex-
pressions of C/EBP b, PPAR g, C/EBP a, aP2 and FAS, and also stimulated adipokines during86 10 8473 8627. Tel.: þ81 0798 45 9956; fax: þ81 0798 45 9951.
a-u.ac.jp (K. Ikeda), jn_sun@sina.com (J. Sun).
f Beijing University of Chinese Medicine.
14.09.004
f Chinese Medicine. Production and hosting by Elsevier B.V. This is an open access article under the CC
mons.org/licenses/by-nc-nd/4.0/).
3,4-Oxo-isopropylidene-shikimic acid 121Figure 1 Chemical structure of
kimic acid (ISA).adipocyte differentiation. Further study should clarify the relationship between stimulation of
adipokines and cognitive enhancing effect of ISA.
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3,4-Oxo-isopropylidene-shikimic acid (ISA, Fig. 1) is a de-
rivative of shikimic acid, which is extracted from star anise
(Illicium verum Hook. Fil.). Its molecular weight is
214.22 g/mol and it has excellent solubility in water. Our
preliminary studies indicated potential therapeutic effect
of ISA on cognitive impairment in APP/PS1 double-
transgenic Alzheimer mice and focal cerebral ischemic
rats.1e3 ISA also suppressed various experimental throm-
bosis in vivo and in vitro.4 There has been increasing in-
terest in metabolism-related effect on brain function.
Retrospective and prospective studies suggest that obesity
increases the risk of developing dementia.5,6 However, lit-
tle is known about the effect of ISA on this metabolic
pathway.
3T3-L1 cell line is one of the most well-researched
models for molecular regulation of adipocyte differentia-
tion,7 and is widely used for studying metabolic syndrome
conditions that include obesity and diabetes mellitus. In
this study, we investigated the effect of ISA on lipid accu-
mulation and secretion of adipokines including adiponectin,
leptin, and resistin during the differentiation of 3T3-L1
preadipocytes into adipocytes.
Materials and methods
Chemicals and reagents
3,4-Oxo-isopropylidene-shikimic acid (ISA, purity > 98%),
provided by School of Materia Medica of Beijing University
of Chinese Medicine, was dissolved in pure water and kept
as a stock solution. Dulbecco’s modified eagle medium
(DMEM), high glucose-DMEM and fetal bovine serum (FBS)
qualified were purchased from Life Technologies (Grand
Island, NY, USA). Penicillin and streptomycin mixed solution3,4-oxo-isopropylidene-shi-was obtained from Nacalai Tesque (Kyoto, Japan). Insulin,
dexamethasone (DEX), dimethyl sulfoxide (DMSO), 3-
isobutyl-1-methylxanthine (IBMX) and triglyceride ELISA
kit were obtained from Wako Pure Chemicals (Osaka,
Japan). Nitro-blue tetrazolium was purchased from Nacalai
Tesque. The RNeasy Mini Kit, RNase-Free DNase Set, QIA
shredder were purchased from QIAGEN (Germantown, MD,
USA). High capacity cDNA reverse transcription kits were
obtained from Applied Biosystems (Tokyo, Japan). The
RNase OUT recombinant ribonuclease inhibitor was ob-
tained from Invitrogen (Carlsbad, CA, USA).Cell culture and treatments
Murine 3T3-L1 preadipocytes (Health Science Research
Resources Bank, Osaka, Japan) were grown on Falcon 6-
well cell culture plates (Becton Dickinson Labware, Franklin
Lakes, NJ, USA) in a 5% CO2 atmosphere at 37
C and
maintained in low glucose DMEM (1000 mg D-glucose/L)
supplemented with 10% FBS, 100 U/mL penicillin and
100 mg/mL streptomycin. The 2-day post-confluent 3T3-L1
cells (designated as Day 0) were incubated with 10% FBS/
high-glucose DMEM (HG-DMEM, 4500 mg D-glucose/L) and
antibiotics, 500 mM 3-isobutyl-1-methylxanthine, 1 mM
dexamethasone, and 5 mg/mL insulin for 3 days (Day 0e2).
Cells were then incubated for 2 days in 10% FBS/HG-DMEM
with insulin (Day 3e4), and thereafter incubated in 10%
FBS/HG-DMEM, which was changed once every 2 days (Day
5e8). Cells receiving ISA were given 10% FBS/HG-DMEM and
insulin containing a final concentration of 50, 200, 400, and
800 mM of ISA in diluted water on Day 3 and Day 4. The
medium was then changed to 10% FBS/HG-DMEM with ISA
for the last 4 days (Day 5e8).Oil red O staining
On Day 8 of differentiation, 3T3-L1 cells were stained with
oil red O to detect droplets in adipocytes. Cells were
washed 3 times with PBS, fixed with 4% paraformaldehyde
for 30 minutes at room temperature, then washed with 60%
isopropanol and dried completely. Thereafter, the fixed
cells were stained with 1.8 mg/mL oil red O working solu-
tion for 30 minutes at room temperature and then washed
twice with 60% isopropanol. Lipid droplets were observed
under light microscopy in PBS.Triglyceride concentration measurement
On Day 8, cells were lysed by RIPA buffer with the protease
inhibitor cocktail and SDS and triglyceride content was
122 S. Dong et al.measured. The triglyceride concentration was corrected by
protein content.
Reverse transcription-polymerase chain reaction
Total RNA was extracted from cultured 3T3-L1 adipocyte
(Day 8) using a RNeasy Mini Kit. Complementary DNA was
generated from 2 mg of total RNA and synthesized using a
high capacity cDNA reverse transcription kit. The PCR con-
ditions were as follows: for glyceraldehydes-3-phosphoate
dehydrogenase (GAPDH), 25 cycles of 95C for 30 seconds,
55C for 30 seconds, 72C for 30 seconds; for resistin, 27
cycles of 95C for 30 seconds, 55C for 30 seconds, 72C for
30 seconds; for peroxisome proliferator-activated receptor
g (PPAR g), adipocyte fatty acid binding protein (aP2), fatty
acid synthase (FAS), 28 cycles of 95C for 30 seconds, 55C
for 30 seconds, 72C for 30 seconds; for CCAAT/enhancer
binding protein b (C/EBP b), 30 cycles of 95C for 30 seconds,
55C for 30 seconds, 72C for 30 seconds; for C/EBP a and
leptin, 31 cycles of 95C for 30 seconds, 55C for 30 seconds,
72C for 30 seconds. To enable comparisons between sam-
ples and groups, quantities of all targets in test samples
were normalized to GAPDH. The oligonucleotide sequences
of all primers are shown in Table 1.
Statistical analysis
All data were presented as mean  SEM and analyzed by
one-way analysis of variance (ANOVA). Multiple group
comparisons were made with the least significant differ-
ence (LSD) post hoc test using SPSS 17.0 software. Statis-
tical significant difference was defined as a value of
P < 0.05.
Results
ISA promoted 3T3-L1 preadipocyte differentiation
into adipocytes and increased intercellular
triglyceride accumulation
Differentiated 3T3-L1 adipocytes began to reserve triglyc-
eride in the cells on Day 4. In this study, the ability of ISA
(200, 400 and 800 mM) to induce lipid accumulation was
examined by oil red O staining and triglyceride content of
3T3-L1 adipocytes was evaluated on Day 8. The data indi-
cated that adipogenesis was stimulated after addition ofTable 1 Primer sequences used for PCR.
Mouse primers Forward primer
C/EBP a ATCCCAGAGGGACTGGA
C/EBP b GTTTCGGGACTTGATGC
PPAR g TTCAGAAGTGCCTGGCT
aP2 AAATCACCGCAGACGAC
FAS CAGTATAAGCCCAAGGC
leptin AGAAGATCCCAGGGAGG
resistin TCATTTCCCCTCCTTTT
GAPDH GAGGACCAGGTTGTCTISA 200e800 mM from Day 3 to Day 8. ISA treatment mark-
edly promoted differentiation of preadipocytes into adi-
pocytes. When compared to mature adipocytes, droplets
observed in the ISA-treated cells were much more intensive
and greater in number (Fig. 2a). Moreover, triglyceride
content of adipocytes was significantly increased by 26%
after ISA 800 mM treatment (P < 0.05) (Fig. 2b).
To evaluate the effect of ISA on adipocyte differentia-
tion, 3T3-L1 preadipocytes were induced to differentiate
into mature adipocytes. 3T3-L1 preadipocyte differentia-
tion to adipocytes gradually occurred with lipid accumula-
tion on Day 4. On Day 7, 3T3-L1 cells were differentiated to
mature adipocytes and generated oil droplets. During the
differentiation process, ISA was added to the medium ata
final concentration of 50, 200, 400 and 800 mM from Day 3 to
Day 8. On Day 8, 3T3-L1 cells were harvested and lysed.
Triglyceride content was then measured by ultraviolet
spectrophotometric method according to the manufac-
turer’s protocol.ISA promoted expressions of transcription factors
during 3T3-L1 preadipocyte differentiation into
adipocytes
CCAAT/enhancer binding proteins (C/EBP) b was expressed
in the early stage of 3T3-L1 differentiation, which was
observed within 1 hour after the addition of induction
medium and served as the regulator of PPAR g and C/EBP a.
PPAR g was transcriptionally induced 2 days after induction
of differentiation and was at a maximum on Day 3e4, which
was necessary and sufficient for adipogenesis in vivo and
in vitro. To detect the effect of ISA on transcription factors,
total RNA was purified on Day 8 from differentiated 3T3-L1
cells and underwent PCR analysis. ISA at 200e800 mM
significantly increased expressions of C/EBP b (by 30%e60%,
P < 0.01, P < 0.001, P < 0.001) and PPAR g (by 16%e30%,
P < 0.05, P < 0.001, P < 0.001). Meanwhile, expression of
C/EBP a was significantly increased by 17% after treatment
with 400 and 800 mM of ISA (P < 0.05) (Fig. 3).
On Day 8, total RNA was extracted from cultured 3T3-L1
adipocytes and preadipocytes using QIAGEN RNeasy mini
kit. Complementary DNA was generated from 2 mg of total
RNA and synthesized by using high capacity cDNA reverse
transcription kit. CCAAT/enhancer-binding protein beta (C/
EBP b), C/EBP a and peroxisome proliferator-activated re-
ceptor gamma (PPAR g) were measured by reverse
transcription-polymerase chain reaction (RT-PCR) usingReverse primer
GTT AAGTCTTAGCCGGAGGAAGC
AAT ATGCTCGAAACGGAAAAGG
GTG TCTTTCCTGTCAAGATCGCC
AG AAATTTCCATCCAGGCCTCT
CAA TAGCCCTCCCGTACACTCAC
AAA TCATTGGCTATCTGCAGCAC
CCT GGCTGCTGTCCAGTCTATCC
CCTG TGTGAGGGAGATGCTCAGTG
Figure 2 ISA promoted 3T3-L1 preadipocyte differentiation into adipocyte and increased intercellular triglyceride accumulation.
a: Oil droplets were stained using oil red O solution. b: Each bar represents mean  SEM, with n Z 3. *P < 0.05 **P < 0.001 vs.
adipocyte group, using one-way ANOVA followed by LSD post hoc test.
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mean  SEM, with nZ 3. *P < 0.05, **P < 0.01, ***P < 0.001
vs. adipocyte group, using one-way ANOVA followed by LSD
post hoc test.ISA increased expressions of PPAR target genes
including aP2 and FAS during 3T3-L1 preadipocyte
differentiation into adipocytes
Peroxisome proliferator-activated receptors (PPARs) are key
transcription factors of lipogenesis and adipogenesis. PPARsmediate the transcription of a group of genes related to
fatty acid synthesis, transport, storage, and energy expen-
diture. PPARs target genes including aP2 and FAS were
evaluated by PCR. FAS and aP2 were markedly expressed in
adipocytes, and interestingly ISA at 50e800 mM significantly
increased expressions of aP2 (P < 0.01, P < 0.001) and FAS
(P < 0.01, P < 0.001) in adipocytes in a dose-dependent
manner (Fig. 4).
Adipocyte-specific acid binding protein (aP2) and fatty
acid synthase (FAS) mRNA gene expression were tested by
RT-PCR method using GAPDH as internal control. Each bar
represents mean  SEM, with nZ 3. *P < 0.01, **P < 0.001
Figure 3 ISA promoted expressions of transcription factors during 3T3-L1 preadipocyte differentiation into adipocytes.
Figure 4 ISA increased expressions of PPAR target genes including aP2 and FAS during 3T3-L1 preadipocyte differentiation into
adipocytes.
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post hoc test.ISA increased adipokinese, including adiponectin,
leptin, and resistin during 3T3-L1 preadipocyte
differentiation into adipocytes
Adiponectin, leptin, and resistin are known as adipokines,
which are mainly secreted by adipose tissue. In this study,
genes of adiponectin, leptin, and resistin were highly
expressed in adipocytes after addition of inductionFigure 5 ISA increased adipokines, including adiponectin, lepti
adipocytes.medium. The adiponectin gene expression was increased
significantly after treatment of ISA at 400 and 800 mM
by 27% and 37% (P < 0.001 and P < 0.001), respectively.
Meanwhile, gene expressions of leptin and resistin were
also increased markedly after addition of ISA at 200e800 mM
(for leptin, by 33%e62%, P< 0.01, P < 0.001; for resistin, by
26%e52%, P < 0.01, P < 0.001) (Fig. 5).
Adipokines, including adiponectin, leptin, and resistin
gene expression were measured by RT-PCR using GAPDH
as internal control. Each bar represents mean  SEM,
with n Z 3. *P < 0.01, **P < 0.001 vs. adipocyte group,
using one-way ANOVA followed by LSD post hoc test.n and resistin during 3T3-L1 preadipocyte differentiation into
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3T3-L1 cells are morphologically similar to fibroblastic pre-
adipose cells in the stroma of adipose tissue. After differen-
tiation, they exhibit virtually all of the characteristics
associatedwith adipocytes presentwithin the adipose tissue.8
After treatment with the differentiation cocktail (insulin,
DEX, IBMX), 3T3-L1preadipocytes undergo differentiation and
progress to mature adipocytes. Members of C/EBP family (C/
EBP b and C/EBP a) and PPAR g play essential roles in this
differentiation process. C/EBP b expresses early in this pro-
cess,which is a prerequisite formitotic clonal expansion,9 and
activates transcription of the C/EBP a and PPAR g. PPAR g and
C/EBP a alone or in cooperation with each other induce the
transcription of many adipocyte genes encoding the proteins
and enzymes, adipocyte P2 gene (aP2) and fatty acid synthase
(FAS), which are the late key markers for maintaining the
phenotype of adipocytes. Among these, aP2 is considered to
be involved in fatty acid transport, storage, and export, and
FAS is a key factor of adipogenesis and lipogenesis.10
Oil droplet accumulation and triglyceride deposition in
3T3-L1 cells were significantly increased after treatment
with ISA, which was the first evidence to demonstrate the
stimulation effects of ISA on triglyceride deposition. These
results indicated that ISA could promote adipocyte differ-
entiation and adipogenesis in the 3T3-L1 cell line. On
mechanistic levels, ISA significantly promoted expressions
of C/EBP b, C/EBP a, and PPAR g, as well as aP2 and FAS,
which lead to the differentiation of adipocytes.
Over the last two decades, increasing studies have
focused on the correlation of high-fat diet and cognition.
Adipokines including leptin, adiponectin, and resistin pro-
duced by adipose tissue, are able to cross the bloodebrain
barrier and may be implicated in cognition deficits.6,11 Spe-
cifically, leptin, a pro-inflammatory adipokine, has been
shown to promote memory, including enhancing long-term
potentiation with consequent cognitive improvement and
also to influence hippocampal synaptic plasticity.12,13
Increasing leptin availability is considered a valid target for
a novel treatment for Alzheimer disease, a hypothesis that
has been confirmed by mechanistic and animal study as well
as ample clinical data.14,15 Adiponectin, an anti-
inflammatory and insulin-sensitizing compound, also exerts
neuroprotective effect in addition to its anti-angiogenic,
anti-atherogenic, and vasodilatory actions.16e19 Evidence
has also demonstrated that resistin has neuroprotective ef-
fects by inhibiting oxidative stress and apoptosis.20
Previously, we focused mainly on the cognitive enhancing
effect of ISA, with preliminary results demonstrating that ISA
appears to improve learning and memory in APP/PS1 double-
transgenic Alzheimermice and focal cerebral ischemic rats. In
this study, the results showed that ISA stimulated expressions
of adiponectin, leptin, and resistin secreted by adipocytes. As
described above, up-regulating of adipokines in adipocytes of
ISA might be implicated in cognitive enhancement of ISA.
However, further confirmatory investigation is needed.
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